Connective-tissue-growth-factor	NN
expression	NN
and	CC
induction	NN
by	IN
transforming-growth-factor-beta	NN
is	VBZ
abrogated	VBN
by	IN
simvastatin	NN
via	IN
a	DT
Rho	NN
signaling	NN
mechanism	NN
.	.

Connective-tissue-growth-factor	NN
(	(
CTGF	NN
)	)
,	,
a	DT
potent	JJ
profibrotic	JJ
mediator	NN
,	,
acts	VBZ
downstream	JJ
and	CC
in	IN
concert	NN
with	IN
transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
beta	NN
to	TO
drive	VB
fibrogenesis	NN
.	.

Significant	JJ
upregulation	NN
of	IN
CTGF	NN
has	VBZ
been	VBN
reported	VBN
in	IN
fibrogenic	JJ
diseases	NNS
,	,
including	VBG
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
,	,
and	CC
is	VBZ
partly	RB
responsible	JJ
for	IN
associated	VBN
excessive	JJ
fibroblast	NN
proliferation	NN
and	CC
extracellular	JJ
matrix	NN
deposition	NN
,	,
but	CC
no	DT
effective	JJ
therapy	NN
exists	VBZ
for	IN
averting	VBG
such	JJ
fibrogeneic	JJ
events	NNS
.	.

Simvastatin	NNP
has	VBZ
reported	VBN
putative	JJ
antifibrotic	JJ
actions	NNS
in	IN
renal	JJ
fibroblasts	NNS
;	:
this	DT
study	NN
explores	VBZ
such	JJ
actions	NNS
on	IN
human	JJ
IPF-derived	JJ
and	CC
normal	JJ
lung	NN
fibroblasts	NNS
and	CC
examines	VBZ
associated	VBN
driving	VBG
mechanisms	NNS
.	.

Simvastatin	NNP
reduces	VBZ
basal	JJ
CTGF	NN
gene	NN
and	CC
protein	NN
expression	NN
in	IN
all	DT
fibroblast	NN
lines	NNS
,	,
overriding	VBG
TGF-beta	NN
induction	NN
through	IN
inhibition	NN
of	IN
the	DT
cholesterol	NN
synthesis	NN
pathway	NN
.	.

Signaling	NN
pathways	NNS
driving	VBG
simvastatin	NN
's	POS
effects	NNS
on	IN
CTGF/TGF-beta	NN
interaction	NN
were	VBD
evaluated	VBN
using	VBG
transient	JJ
reporter	NN
transfection	NN
of	IN
a	DT
CTGF	NN
promoter	NN
construct	NN
.	.

Inhibition	NN
of	IN
CTGF	NN
promoter	NN
activity	NN
by	IN
simvastatin	NN
was	VBD
most	RBS
marked	JJ
at	IN
10	CD
muM	JJ
concentration	NN
,	,
reducing	VBG
activity	NN
by	IN
76.2	CD
and	CC
51.8	CD
%	NN
over	IN
TGF-beta-stimulated	JJ
cultures	NNS
in	IN
IPF	NN
and	CC
normal	JJ
fibroblasts	NNS
,	,
respectively	RB
.	.

We	PRP
also	RB
show	VBP
that	IN
geranylgeranylpyrophosphate	NN
(	(
GGPP	NN
)	)
,	,
but	CC
not	RB
farnesylpyrophosphate	NN
,	,
induces	VBZ
CTGF	NN
promoter	NN
activity	NN
following	VBG
simvastatin	NN
inhibition	NN
by	IN
55.3	CD
and	CC
31.1	CD
%	NN
over	IN
GGPP-negative	JJ
cultures	NNS
in	IN
IMR90	NN
and	CC
IPF-derived	JJ
fibroblasts	NNS
,	,
respectively	RB
,	,
implicating	VBG
small	JJ
GTPase	NN
Rho	NN
involvement	NN
rather	RB
than	IN
Ras	NN
in	IN
these	DT
effects	NNS
.	.

Indeed	RB
,	,
the	DT
specific	JJ
Rho	NN
inhibitor	NN
C3	NN
exotoxin	NN
significantly	RB
(	(
P	NN
<	JJR
0.05	CD
)	)
suppressed	VBD
TGF-beta-induced	JJ
CTGF	NN
promoter	NN
activity	NN
in	IN
transfected	VBN
lung	NN
fibroblasts	NNS
,	,
a	DT
finding	NN
further	JJ
supported	VBN
by	IN
transfection	NN
of	IN
dominant-negative	JJ
and	CC
constitutively	RB
active	JJ
RhoA	NN
constructs	NNS
,	,
thus	RB
demonstrating	VBG
that	IN
simvastatin	NN
through	IN
a	DT
Rho	NN
signaling	NN
mechanism	NN
in	IN
lung	NN
fibroblasts	NNS
can	MD
modulate	VB
CTGF	NN
expression	NN
and	CC
interaction	NN
with	IN
TGF-beta	NN
.	.

